Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Coferon Inc.
Based on research from the University of North Carolina and seeded by Hatteras Venture Partners, the start-up is developing cyclin-dependent kinase (CDK) 4/6 inhibitors for use in protecting the bone marrow of cancer patients receiving chemotherapy. The funding should bring the biotech through IND filing and into Phase I work.
Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.
START-UP's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical equipment & supplies.
The latest news on digital health partnerships and research.
- Site Specific
- Drug Delivery
- Other Names / Subsidiaries
- Blink Bio